← Open Payments lookup

GWENDOLYN WRIGHT: Open Payments

NPI 1467832246 · GRAND BLANC, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$25,139 in 140 payments from 20 companies in 2025. Trend: 2023 $5,529 · 2024 $11,686 · 2025 $25,139

Speaker / faculty: $13,134Travel & lodging: $4,460Food & beverage: $3,884Consulting: $3,616Education: $46
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.24$8,816
Salix Pharmaceuticals, a division of Bausch Health US, LLC22$7,169
ABBVIE INC.33$3,612
GENZYME CORPORATION8$3,022
Ipsen Biopharmaceuticals, Inc9$1,174
Regeneron Healthcare Solutions, Inc.7$253
Janssen Biotech, Inc.7$199
Ardelyx, Inc.4$154
Intercept Pharmaceuticals, Inc.2$135
Lilly USA, LLC5$108

Products named: ENTYVIO, XIFAXAN, LINZESS, TRULANCE, Bylvay, DUPIXENT, SKYRIZI, RINVOQ.

Industry payments across MI — which companies pay providers there.